Cyclosporin: nephro-protective as well as nephrotoxic?
Mathieson
P W
PW
D000818:Animals; D015815:Cell Adhesion Molecules / Q000096:biosynthesis / Q000235:genetics; D016572:Cyclosporine / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D004195:Disease Models, Animal; D005355:Fibrosis; D005786:Gene Expression Regulation / Q000187:drug effects; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D007668:Kidney / Q000187:drug effects / Q000473:pathology; D007674:Kidney Diseases / Q000139:chemically induced*; D016030:Kidney Transplantation / Q000276:immunology*; D051381:Rats; D012713:Serum Sickness / Q000188:drug therapy / Q000378:metabolism; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use; D016212:Transforming Growth Factor beta / Q000502:physiology
D015815:Cell Adhesion Molecules; D007166:Immunosuppressive Agents; D016212:Transforming Growth Factor beta; D016572:Cyclosporine; D016559:Tacrolimus